{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:58:03Z","timestamp":1790006283607,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jpedsurg.2016.09.070","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T18:15:18Z","timestamp":1476728118000},"page":"618-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma"],"prefix":"10.1016","volume":"52","author":[{"given":"Chenwei","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzhi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0005","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0010","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpeds.2004.09.011","article-title":"The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation","volume":"146","author":"Tiao","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00383-009-2349-3","article-title":"Survival trends in children with hepatoblastoma","volume":"25","author":"Horton","year":"2009","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0020","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ejca.2011.12.011","article-title":"Prognostic stratification for children with hepatoblastoma: the SIOPEL experience","volume":"48","author":"Maibach","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0025","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ejso.2014.07.033","article-title":"Predictors of survival after resection of children with hepatoblastoma: a single Asian center experience","volume":"40","author":"Qiao","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-015-0162-0","article-title":"MiRNA-based therapeutic intervention of cancer","volume":"8","author":"Naidu","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0040","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0045","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0050","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.3892\/or.2014.3515","article-title":"Circulating miR-199a-3p as a novel serum biomarker for colorectal cancer","volume":"32","author":"Nonaka","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1155\/2013\/259454","article-title":"Serum circulating microRNA profiling for identification of potential breast cancer biomarkers","volume":"34","author":"Mar-Aguilar","year":"2013","journal-title":"Dis Markers"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00432-012-1315-y","article-title":"Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer","volume":"139","author":"Si","year":"2013","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1479-5876-10-55","article-title":"Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma","volume":"10","author":"Redova","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0070","doi-asserted-by":"crossref","first-page":"e30679","DOI":"10.1371\/journal.pone.0030679","article-title":"The majority of microRNAs detectable in serum and saliva is concentrated in exosomes","volume":"7","author":"Gallo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-015-0181-x","article-title":"Exosomes in cancer: small particle, big player","volume":"8","author":"Zhang","year":"2015","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0080","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/14737159.2014.922879","article-title":"MicroRNAs in the tumor microenvironment: solving the riddle for a better diagnostics","volume":"14","author":"Challagundla","year":"2014","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00428-010-1030-5","article-title":"Frequent concomitant inactivation of miR-34a and miR-34b\/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas","volume":"458","author":"Vogt","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0090","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrc3318","article-title":"MicroRNAs in the p53 network: micromanagement of tumour suppression","volume":"12","author":"Hermeking","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0095","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2174\/13894501113149990191","article-title":"Functional role of miR-34 family in human cancer","volume":"14","author":"Wang","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12032-012-0413-7","article-title":"Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis","volume":"30","author":"Javeri","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lungcan.2011.10.002","article-title":"Frequent methylation and oncogenic role of microRNA-34b\/c in small-cell lung cancer","volume":"76","author":"Tanaka","year":"2012","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.jpedsurg.2016.09.070_bb0110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.jpedsurg.2016.02.091","article-title":"Combined low miR-34s are associated with unfavorable prognosis in children with hepatoblastoma: a Chinese population-based study","volume":"51","author":"Jiao","year":"2016","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0115","first-page":"307","article-title":"Receiver operating characteristic (ROC) methodology: the state of the art","volume":"29","author":"Hanley","year":"1989","journal-title":"Crit Rev Diagn Imaging"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0120","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"DR","year":"1972","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0125","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cncr.10282","article-title":"Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group","volume":"94","author":"Schnater","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/ki.2012.25","article-title":"A multiplex quantitative proteomics strategy for protein biomarker studies in urinary exosomes","volume":"81","author":"Raj","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0135","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/intimm\/dxh267","article-title":"Exosomal-like vesicles are present in human blood plasma","volume":"17","author":"Caby","year":"2005","journal-title":"Int Immunol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0140","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0959-8049(97)00095-6","article-title":"Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology","volume":"33","author":"von Schweinitz","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0145","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/pbc.22088","article-title":"Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group","volume":"53","author":"Meyers","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0150","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","article-title":"Pretreatment prognostic factors for children with hepatoblastoma\u2014results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1","volume":"36","author":"Brown","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0155","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P","article-title":"Prognostic factors and staging systems in childhood hepatoblastoma","volume":"74","author":"von Schweinitz","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0160","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.1997.15.3.1190","article-title":"Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group","volume":"15","author":"Van Tornout","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fgene.2012.00120","article-title":"miR-34\u2014a microRNA replacement therapy is headed to the clinic","volume":"3","author":"Bader","year":"2012","journal-title":"Front Genet"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0170","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4161\/cc.9.6.10987","article-title":"microRNA-34a is tumor suppressive in brain tumors and glioma stem cells","volume":"9","author":"Guessous","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0175","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.2174\/13816128113199990325","article-title":"MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2","volume":"19","author":"Fan","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0180","doi-asserted-by":"crossref","first-page":"e76540","DOI":"10.1371\/journal.pone.0076540","article-title":"Effects of microRNAs on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells","volume":"8","author":"Bernardi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0185","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/mol.109.063321","article-title":"MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells","volume":"77","author":"Ichimura","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0190","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1158\/0008-5472.CAN-08-0325","article-title":"Epigenetic silencing of microRNA-34b\/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer","volume":"68","author":"Toyota","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0195","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s13277-012-0632-8","article-title":"Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells","volume":"34","author":"Cao","year":"2013","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0200","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","article-title":"Transcriptional activation of miR-34a contributes to p53-mediated apoptosis","volume":"26","author":"Raver-Shapira","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.jpedsurg.2016.09.070_bb0205","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cub.2007.06.068","article-title":"p53-mediated activation of miRNA34 candidate tumor-suppressor genes","volume":"17","author":"Bommer","year":"2007","journal-title":"Curr Biol"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346816304584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346816304584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:15:39Z","timestamp":1718842539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346816304584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0022346816304584"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.09.070","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal miR-34s panel as potential novel diagnostic and prognostic biomarker in patients with hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2016.09.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}